Skip to main content
Premium Trial:

Request an Annual Quote

MSI Releases Moleculizer Software to Address Combinatorial Explosion of Reaction Networks


There is a growing set of tools available to researchers for simulating intracellular biochemical networks, but a new package from the Molecular Sciences Institute claims to have raised the bar a few notches.

The software, Moleculizer 1.0, generates reaction networks during the simulation process — a capability that other packages do not have, according to Larry Lok and Roger Brent of MSI, who published a paper on the stochastic simulation method in the January 2005 issue of Nature Biotechnology.

Other packages can either generate reaction networks or run the simulation, but Moleculizer can do both, and therefore “generates molecular complexes on the fly,” as the simulation is running, Brent said.

Moreover, the method addresses a major drawback of computationally predicting cellular networks — the so-called combinatorial explosion that occurs when all potential reactions and complexes are generated at once — by generating only those complexes that are needed as the simulation progresses. This generates a much smaller reaction network than other methods, which makes it easier for computers — and researchers — to process the output.

As an example, Brent noted that in the primary pathway the MSI research team is studying — the yeast mating pheromone signal transduction, or alpha, pathway — one cascade alone is comprised of 480 known molecules that could interact in more than 20,000 possible combinations — an “absurd” number for a biologist to wade through, Brent said. If the entire pathway were to be considered, he said, that would generate “an inconceivable number of possible [molecular] species.”

Moleculizer’s reaction network generator begins with a single “triggering” molecule, along with its specifications for binding, unbinding, and other reactions. The program builds out the network in an iterative manner, creating all possible reactions for a single molecule at a time, which may or may not be used by the program’s simulator as it progresses. Only those molecular species required by the simulator continue in the iterative process as the network is created.

Brent and Lok said that the networks generated by Moleculizer could be used as input for other simulation software packages, and that the team plans to enable conversion of Moleculizer-generated networks to SBML (Systems Biology Markup Language), Level 3, in order to facilitate this exchange.

Lok said that the MSI team is currently using the software as an “heuristic tool” to aid MSI’s wet lab activities, which currently account for around 80 percent of the institute’s effort to model the alpha pathway.

The software is available under the GPL at Lok warned, however, that Moleculizer “is not for the faint of heart.” Rather, he said, it’s designed with the requirements of “hardcore simulation geeks” in mind — an extremely small community, by Lok and Brent’s estimation.

Nevertheless, future development plans call for a web interface through which researchers will be able to run simulations online, as well as an improved network-generation method that accounts for the geometry of molecules.

The MSI developers are integrating Moleculizer with a number of collaborative biosimulation packages, including E-Cell, MONOD (Modeler’s Notebook and Datastore), ChemCell, and the Systems Biology Workbench.

— BT


Filed under

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.